SNT 2.56% 3.8¢ syntara limited

I agree Splitview, I dont believe there is anything "wrong" with...

  1. 163 Posts.
    I agree Splitview, I dont believe there is anything "wrong" with the drug itself that is stopping approval in Europe, it appears that some result inconsistancies between patient age ranges has occured, especially adolescents as compared to adults.

    Remember the TGA has approved this drug here in OZ
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
-0.001(2.56%)
Mkt cap ! $45.37M
Open High Low Value Volume
3.9¢ 4.0¢ 3.7¢ $66.86K 1.754M

Buyers (Bids)

No. Vol. Price($)
1 82150 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.8¢ 452640 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.